← FDA Drug Approvals (Drugs@FDA)

KATERZIA

NDA · New Drug Application · Sponsor: AZURITY · Approved 2019-07-08

Drug application

FDA Application #

NDA211340

Application type

New Drug Application

Brand name

KATERZIA

Generic name

AMLODIPINE

Active ingredients

AMLODIPINE BENZOATE

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

AZURITY

Manufacturer

Azurity Pharmaceuticals, Inc.

First approval

2019-07-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown